ES2168263T3 - Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados. - Google Patents

Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados.

Info

Publication number
ES2168263T3
ES2168263T3 ES93107543T ES93107543T ES2168263T3 ES 2168263 T3 ES2168263 T3 ES 2168263T3 ES 93107543 T ES93107543 T ES 93107543T ES 93107543 T ES93107543 T ES 93107543T ES 2168263 T3 ES2168263 T3 ES 2168263T3
Authority
ES
Spain
Prior art keywords
tubed
patients
less
caloric density
low caloric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93107543T
Other languages
English (en)
Inventor
David A Mark
Lance Stalker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25390987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2168263(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2168263T3 publication Critical patent/ES2168263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/804—Low calorie, low sodium or hypoallergic

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

LA PRESENTE INVENCION PRESENTA UN PRODUCTO ENTERAL PARA PROPORCIONAR LOS REQUERIMIENTOS NUTRICIONALES A UN PACIENTE, QUE COMPRENDE: UN CONTENIDO CALORICO MENOR DE 1,00 KCAL/ML; UNA OSMOLARIDAD INFERIOR A 300 MOSM; Y UN CONTENIDO DE FIBRA SUPERIOR A 15 GMS/ML PREFERENTEMENTE. ADEMAS, LA PRESENTE INVENCION PRESENTA UN METODO PARA PROPORCIONAR NUTRICION A UN PACIENTE A TRAVES DE UN PRODUCTO ENTERAL ADMINISTRADO POR UN TUBO Y REDUCIR EL RIESGO DE QUE SE PRODUZCA UNA DIARREA, QUE CONSISTE EN LOS PASOS SIGUIENTES: PROPORCIONAR UN PRODUCTO ENTERAL ESTERIL, QUE NO HAGA FALTA DILUIR, Y QUE TENGA UNA OSMOLARIDAD MENOR DE 300 MOSM Y UN CONTENIDO CALORICO INFERIOR A 1,0 KCAL/ML, PERO QUE TENGA UN CONTENIDO DE FIBRA SUPERIOR A 15 GMS/LITRO; Y ADMINISTRAR ENTERALMENTE EL PRODUCTO A UN PACIENTE.
ES93107543T 1992-05-21 1993-05-10 Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados. Expired - Lifetime ES2168263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/887,361 US5229136A (en) 1992-05-21 1992-05-21 Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients

Publications (1)

Publication Number Publication Date
ES2168263T3 true ES2168263T3 (es) 2002-06-16

Family

ID=25390987

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93107543T Expired - Lifetime ES2168263T3 (es) 1992-05-21 1993-05-10 Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados.

Country Status (10)

Country Link
US (1) US5229136A (es)
EP (1) EP0570791B1 (es)
JP (1) JP3644023B2 (es)
AT (1) ATE210387T1 (es)
AU (1) AU3851993A (es)
CA (1) CA2095889C (es)
DE (1) DE69331296T2 (es)
DK (1) DK0570791T3 (es)
ES (1) ES2168263T3 (es)
PT (1) PT570791E (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
AU1928295A (en) * 1994-02-25 1995-09-11 New England Deaconess Hospital Corporation Anti-inflammatory and infection protective effects of sesamin-based lignans
US5447741A (en) * 1994-04-05 1995-09-05 Goldman; Marc S. Milk composition containing fiber and method for making same
US5753295A (en) * 1994-04-05 1998-05-19 Goldman; Marc S. Non-dairy composition containing fiber and method for making same
US5558897A (en) * 1994-04-05 1996-09-24 Goldman; Marc S. Milk composition containing fiber and method for making same
ES2123903T5 (es) * 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
JP3556757B2 (ja) * 1996-02-09 2004-08-25 森永乳業株式会社 吸収促進性糖類組成物
US5767815A (en) * 1996-06-20 1998-06-16 Andrew Corporation Antenna feedhorn with protective window
US5776463A (en) * 1997-02-19 1998-07-07 Arginteanu; Ronit Method of reducing stress and circulatory heart disease with freeze-dried borage petal extracts
CA2283573A1 (en) * 1997-03-13 1998-09-17 Merlin D. Breen Nutritional formula containing hydrolyzed protein and a fiber blend
US5849335A (en) * 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
DE10261061A1 (de) * 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
GB0622582D0 (en) * 2006-11-13 2006-12-20 Biotec Pharmacon Asa Animal feeds and veterinary compositions
CN101896176A (zh) * 2007-10-14 2010-11-24 佛罗里达大学研究基金公司 改善胃肠道功能的制剂
WO2010082390A1 (ja) * 2009-01-19 2010-07-22 ニュートリー株式会社 低濃度の栄養組成物
DK2528456T3 (da) 2010-01-29 2014-07-14 Nutricia Nv Væskeformig enteral næringssammensætning egnet til sondemadning
TWI615097B (zh) * 2011-05-13 2018-02-21 Meiji Co Ltd 具黏性之液狀之營養組合物
US9522131B2 (en) 2013-01-11 2016-12-20 Wisconsin Alumni Research Foundation Tannin-containing gastrointestinal formulations and methods of use
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (en) 2017-08-14 2020-06-24 Axcella Health Inc. Amino acid compositions for the treatment of liver disease
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
JP7412627B1 (ja) * 2023-08-14 2024-01-12 サントリーホールディングス株式会社 容器詰めの大豆成分含有飲料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
ZA86415B (en) * 1985-01-29 1986-09-24 Abbott Lab Enteral nutritional hypoallergenic formula
EP0214317B1 (fr) * 1985-08-30 1988-08-17 Societe Des Produits Nestle S.A. Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance

Also Published As

Publication number Publication date
US5229136A (en) 1993-07-20
EP0570791B1 (en) 2001-12-12
DK0570791T3 (da) 2002-04-02
DE69331296D1 (de) 2002-01-24
CA2095889C (en) 2003-07-15
JP3644023B2 (ja) 2005-04-27
DE69331296T2 (de) 2002-06-13
EP0570791A2 (en) 1993-11-24
JPH0656693A (ja) 1994-03-01
PT570791E (pt) 2002-05-31
ATE210387T1 (de) 2001-12-15
AU3851993A (en) 1993-11-25
EP0570791A3 (en) 1995-03-29
CA2095889A1 (en) 1993-11-22

Similar Documents

Publication Publication Date Title
ES2168263T3 (es) Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados.
US5661123A (en) Enteral composition for malabsorbing patients
US4981844A (en) Method to improve immune response and resistance to infection following surgery by diet composition
US5766621A (en) Support of pediatric patients
DE69806820T2 (de) Kaloriereiche ernährungszusammensetzung
US5723446A (en) Enteral formulation designed for optimized nutrient absorption and wound healing
MX9304468A (es) Producto nutritivo enteral para personas que tienen un daño neurologico.
ES2177716T3 (es) Nutricion para pacientes mayores.
DK0626175T3 (da) Enteralt ernæringsprodukt
AR015057A1 (es) Producto alimenticio liquido elemental, metodo para proveer nutricion a un paciente, proteinas apropiadas para la incorporacion a productos alimenticiosliquidos elementales, y metodo para mejorar el gusto de los productos alimenticios liquidos elementales
ES2081066T3 (es) Composiciones para uso dietetico y terapeutico que comprenden glucidos y sus aplicaciones.
SE9103395D0 (sv) System med anvaendning av ensteril medicinsk loesning innehaallande glukos eller glukosliknande aemnen samt en loesning avsedd foer detta system
IL106976A0 (en) Nutrition for persons undergoing radiation therapy and/or chemotherapy
CA2508280C (en) An aseptically packaged, extensively hydrolyzed, liquid nutritional formula and method for making it
Bendich Vitamins and immunity
CA2150741A1 (en) Pediatric lipid emulsion
EP0564804A1 (en) Improved high protein liquid nutrition for patients with elevated wound healing requirements
NO308502B1 (no) Høykaloriholdig ernærings-løsning med lav osmolalitet, for parenteral tilførsel
McCabe et al. Evaluation of a phenylalanine-free product for treatment of phenylketonuria
Driscoll Physicochemical stability of all-in-one mixtures inclinical setting
Wenderoth Aspects of the new eicosanoid-research.).
MX9803212A (es) Productos alimenticios no grasos y bajos en grasa con sabor mejorado.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 570791

Country of ref document: ES